SITIY yields 10.41% · JNJ yields 2.13%● Live data
📍 SITIY pulled ahead of the other in Year 1
Combined, SITIY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SITIY + JNJ for your $10,000?
SITC International Holdings Company Limited, a shipping logistics company, provides integrated transportation and logistics solutions in Mainland China, Hong Kong, Taiwan, Japan, Southeast Asia, and internationally. It operates through two segments, Container Shipping and Logistics; and Dry Bulk and Others. The Container Shipping and Logistics segment offers container transportation, freight forwarding, shipping agency, and depot and warehousing services. The Dry Bulk and Others segment provides dry bulk vessel and land leasing, as well as air freight forwarding services. As of December 31, 2021, the company operated a fleet of 96 vessels with a total capacity of 143,115 TEU, including 68 self-owned vessels with a capacity of 103,663 TEU and 28 chartered vessels with a capacity of 39,452 TEU; and 5 dry bulk vessels with a total tonnage of 362,000 tons. It also offers container and vessel holding, and chartering; technology support; container maintenance; customs declaration; and multimodal transportation services. The company was founded in 1991 and is headquartered in Wan Chai, Hong Kong. SITC International Holdings Company Limited is a subsidiary of Resourceful Link Management Limited.
Full SITIY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.